KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Resmed (RMD) Non Operating Income (2016 - 2025)

Resmed's Non Operating Income history spans 17 years, with the latest figure at $4.5 million for Q4 2025.

  • For Q4 2025, Non Operating Income rose 102.53% year-over-year to $4.5 million; the TTM value through Dec 2025 reached -$4.8 million, down 105.47%, while the annual FY2025 figure was -$5.3 million, 50.43% down from the prior year.
  • Non Operating Income reached $4.5 million in Q4 2025 per RMD's latest filing, up from $256000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $26.0 million in Q2 2023 to a low of -$16.8 million in Q3 2023.
  • Average Non Operating Income over 5 years is -$2.6 million, with a median of -$2.2 million recorded in 2021.
  • Peak YoY movement for Non Operating Income: plummeted 1227.09% in 2022, then skyrocketed 954.62% in 2023.
  • A 5-year view of Non Operating Income shows it stood at -$11.4 million in 2021, then skyrocketed by 85.06% to -$1.7 million in 2022, then tumbled by 816.23% to -$15.6 million in 2023, then surged by 114.17% to $2.2 million in 2024, then surged by 102.53% to $4.5 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Non Operating Income are $4.5 million (Q4 2025), $256000.0 (Q3 2025), and -$979000.0 (Q2 2025).